You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

symjepi Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Symjepi, and what generic alternatives are available?

Symjepi is a drug marketed by Adamis Pharms Corp and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-two patent family members in seventeen countries.

The generic ingredient in SYMJEPI is epinephrine. There are twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Symjepi

A generic version of symjepi was approved as epinephrine by BPI LABS on July 29th, 2014.

  Try a Trial

US Patents and Regulatory Information for symjepi

symjepi is protected by one US patents.

Patents protecting symjepi

Syringe devices
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF EPINEPHRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Adamis Pharms Corp SYMJEPI epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 207534-002 Sep 27, 2018 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Adamis Pharms Corp SYMJEPI epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 207534-001 Jun 15, 2017 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for symjepi

See the table below for patents covering symjepi around the world.

Country Patent Number Title Estimated Expiration
New Zealand 754639 Syringe devices ⤷  Try a Trial
European Patent Office 4079351 DISPOSITIFS DE SERINGUE (SYRINGE DEVICES) ⤷  Try a Trial
Japan 2020192375 注射器デバイス (SYRINGE DEVICES) ⤷  Try a Trial
Canada 3199029 DISPOSITIFS DE TYPE SERINGUE (SYRINGE DEVICES) ⤷  Try a Trial
South Africa 201800998 SYRINGE DEVICES ⤷  Try a Trial
Australia 2016313110 Syringe devices ⤷  Try a Trial
New Zealand 773712 Syringe devices ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.